ASCLETIS-B (01672) spent 2.4837 million Hong Kong dollars to repurchase 200,000 shares on December 23rd.
Sing Lee Pharmaceuticals Group Limited (01672) announced on December 23, 2025 the repurchase of 200,000 shares at a cost of HK$2.4837 million.
ASCLETIS-B (01672) announced that it will spend HKD 2.4837 million to repurchase 200,000 shares on December 23, 2025.
Related Articles
DINGDANG HEALTH (09886) spent HK $114,000 on December 23 to buy back 101,500 shares.
Shangda Superalloys (301522.SZ) has received a long-term supply confirmation letter from a leading overseas aviation company.
CHENGDU EXPWAY (01785) elects Pan Xin as employee director (non-executive director)
DINGDANG HEALTH (09886) spent HK $114,000 on December 23 to buy back 101,500 shares.
Shangda Superalloys (301522.SZ) has received a long-term supply confirmation letter from a leading overseas aviation company.
CHENGDU EXPWAY (01785) elects Pan Xin as employee director (non-executive director)
RECOMMEND
